Confirma(R), pioneer and leader in application-specific CAD for MRI, announced the introduction of CADstream for prostate for improved analysis and reporting of the prostate. The prostate application will offer radiologists comprehensive and clinically valuable tools for improved quality, standardization and efficiency of MRI studies. CADstream for prostate will be presented at the upcoming Radiological Society of North America (RSNA) meeting, the largest medical meeting in the world and the pre-eminent venue for introducing new technologies for radiology (November 25-27, Chicago). At the meeting, the company will also introduce the next generation of CADstream for breast MRI.
"Over the past five years, CADstream for breast MRI has received broad-scale acceptance from the women's imaging community," said Wayne Wager, president and CEO, Confirma, Inc. "We believe that prostate research studies and ongoing development with our clinical sites will help establish CAD within the men's imaging community. CAD provides physicians with valuable tools to improve the detection of cancer and treatment planning."
MedicalNewsToday
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment